The mechanism of action of intravenous immunoglobulin (IVIG) in demyelinating neuropathies

By Pollard J.D.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 72-73

Elsevier

Access to resources Recommend Favorite

Anti‐ganglioside antibody‐mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies

By Zhang G.  

Brain, Vol. 127, Iss. 5, 2004-05 ,pp. : 1085-1100

Oxford University Press

Access to resources Recommend Favorite

The trial study of chronic inflammatory demyelinating polyneuropathy (CIDP) with intravenous immunoglobulin (IVIG) in Japan

By Hirose G.   Kimura J.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 71-72

Elsevier

Access to resources Recommend Favorite

Hereditary demyelinating neuropathies: from gene to disease

By Hanemann C.O.  

Neurogenetics, Vol. 3, Iss. 2, 2001-03 ,pp. : 53-57

Springer Publishing Company

Access to resources Recommend Favorite

Safety and tolerability of intravenous immunoglobulin

By Martin T.D.  

Electroencephalography and Clinical Neurophysiology, Vol. 103, Iss. 1, 1997-07 ,pp. : 52-53

Elsevier

Access to resources Recommend Favorite